Cotinga Pharmaceuticals Inc. (COTQF)
COTQF Stock Price Chart
Explore Cotinga Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze COTQF price movements and trends.
COTQF Company Profile
Discover essential business fundamentals and corporate details for Cotinga Pharmaceuticals Inc. (COTQF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Sept 2009
Employees
—
Website
https://www.cotingapharma.comCEO
Richard T. Ho
Description
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
COTQF Financial Timeline
Browse a chronological timeline of Cotinga Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
COTQF Stock Performance
Access detailed COTQF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.